Table 2. Prognostic outcome of the INTERSTELLAR cohort according to CI-AKI and HLI states.
| Total (n = 668) | No organ damage (n = 465) | CI-AKI only (n = 47) | HLI only (n = 130) | Combined CI-AKI and HLI (n = 26) | |
|---|---|---|---|---|---|
| 30-day mortality | 38 (5.7%) | 14 (3.0%) | 3 (6.4%) | 12 (9.2%) | 9 (34.6%) |
| Composite MACCE | 94 (14.1%) | 45 (9.7%) | 10 (21.3%) | 24 (18.5%) | 15 (57.7%) |
| All-cause mortality | 66 (9.9%) | 24 (5.2%) | 10 (21.3%) | 19 (14.6%) | 13 (50.0%) |
| Non-fatal MI | 15 (2.2%) | 13 (2.8%) | 0 (0%) | 2 (1.5%) | 0 (0%) |
| Non-fatal stroke | 7 (1.0%) | 3 (0.6%) | 0 (0%) | 3 (2.3%) | 1 (3.8%) |
| TLR/TVR | 6 (0.9%) | 5 (1.1%) | 0 (0%) | 0 (0%) | 1 (3.8%) |
Data are expressed as numbers (%). Abbreviations. MACCE = major adverse cardiovascular and cerebrovascular event; MI = myocardial infarction; TLR = target lesion revascularization; TVR = target vessel revascularization; CI-AKI = contrast induced acute kidney injury; HLI = hypoxic liver injury.